Lipid Management in Patients With Coronary Artery Disease by a Clinical Pharmacy Service in a Group Model Health Maintenance Organization

Olson, Kari L.; Rasmussen, Jon; Sandhoff, Brian G.; Merenich, John A.

doi:10.1001/archinte.165.1.49

Cited by 58 publications

(37 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Insurance products characterized as "others" are high deductible or triple option in our system; this association could reflect a particular patient-employer subset. At KPCO, antihyperlipidemic therapy is often instituted by a centralized pharmacist managed, physician monitored service, 32,33 and at primary care medical offices, clinical pharmacy specialists conduct lipid management. These services likely in part explain the association between prescribing by a non-primary care department and the antihyperlipidemic subgroup.…”

Section: Discussionmentioning

confidence: 99%

Characteristics of Patients with Primary Non-adherence to Medications for Hypertension, Diabetes, and Lipid Disorders

et al. 2011

View full text Add to dashboard Cite

show abstract

Section: Discussionmentioning

confidence: 99%

Characteristics of Patients with Primary Non-adherence to Medications for Hypertension, Diabetes, and Lipid Disorders

et al. 2011

View full text Add to dashboard Cite

show abstract

“…Consistent with other studies within the coronary artery disease population, males were more likely to be at goal. [23][24][25][26] Patients with diabetes were also more likely to attain goal. This finding may have been influenced by a KPCO initiative targeting statin initiation in patients with diabetes based on the results of the Heart Protection Study.…”

Section: Discussionmentioning

confidence: 99%

An assessment of cholesterol goal attainment in patients with chronic kidney disease

Stadler

Bhardwaja

Olson

et al. 2010

Journal of Clinical Lipidology

Self Cite

View full text Add to dashboard Cite

“…A more recent study, using a before-after design, evaluated the impact of a clinical pharmacy cardiac risk service on lipid screening, control, and treatment outcomes in more than 8,000 middle-aged and elderly male and female enrollees of a large group model health maintenance organization. The results of this study showed improvements in the outpatient management of LDL cholesterol levels as well as enhanced screening efforts for the identification of patients with elevated serum lipid levels [9]. …”

Section: Discussionmentioning

confidence: 99%

Survey of Physician’s Attitudes and Practices toward Lipid-Lowering Management Strategies

Goldberg

Rosen²,

Roselli³

et al. 2007

Cardiology

View full text Add to dashboard Cite

Background: The purpose of the present study was to examine physician’s attitudes and practices toward the use of different lipid-lowering management strategies in patients at increased risk for coronary heart disease (CHD). Aims/Methods: An internet-based questionnaire was completed by 78 general internists and family practitioners (mean age = 49 years; 80% male) affiliated with a large primary care health delivery system in Connecticut. Questions were asked about physician knowledge and use of current national guidelines for lipid-lowering therapy and their treatment practices for patients at varying risk for CHD. Results: Most physicians reported they were very knowledgeable about different interventions to lower serum lipids. Most (92%) indicated that they were aware of and followed national guidelines for the treatment of patients with hyperlipidemia the majority of the time. Physicians were likely to initiate lipid-lowering therapy at lower levels of serum LDL cholesterol in patients at high, as compared to those at moderate, risk for coronary disease. Targeted treatment levels were also reported to be considerably lower for patients at higher risk, than for those at moderate risk, for the development of coronary disease. Diabetes, cigarette smoking, and elevated LDL cholesterol levels were reported to be the three most important risk factors for CHD by the physician sample. Gaps in the recommendation of lifestyle changes to patients with hyperlipidemia were observed. Conclusions: Despite adequate physician knowledge, achieving desirable serum lipid levels in primary care patients remains elusive. Provider education is needed to optimize the care of patients with elevated serum lipids treated in the primary care setting.

show abstract

Lipid Management in Patients With Coronary Artery Disease by a Clinical Pharmacy Service in a Group Model Health Maintenance Organization

Cited by 58 publications

References 22 publications

Characteristics of Patients with Primary Non-adherence to Medications for Hypertension, Diabetes, and Lipid Disorders

Characteristics of Patients with Primary Non-adherence to Medications for Hypertension, Diabetes, and Lipid Disorders

An assessment of cholesterol goal attainment in patients with chronic kidney disease

Survey of Physician’s Attitudes and Practices toward Lipid-Lowering Management Strategies

Contact Info

Product

Resources

About